Status:
RECRUITING
HEME Home Transfusion Program
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Myeloma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is evaluating whether a new care delivery program that provides access to home blood transfusions in hospice (i.e, HEME-Hospice) compared to regular standard of care improves quali...
Detailed Description
Lack of access to blood transfusions is a key barrier to timely hospice use for patients with blood cancers. Refractory anemia and thrombocytopenia are common for patients with blood cancers and resul...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Patient Participants:
- Diagnosis of a relapsed/refractory hematologic malignancy
- Age ≥ 18 years
- Receipt of primary oncologic care at DFCI (at least 2 outpatient visits in 12 months prior to enrollment)
- Has received at least one red blood cell (RBC) or platelet transfusion since blood cancer diagnosis in the clinic or hospital setting without a severe transfusion reaction
- Patient resides within catchment served by Care Dimensions Hospice
- Physician-estimated prognosis of six months or less
- Inclusion Criteria for Caregivers:
- Identified informal caregiver of enrolled patient with hematologic malignancy
- Age ≥ 18 years
- Exclusion Criteria for Patient Participants:
- Age \< 18 years
- Already enrolled in hospice
- Resides in nursing home or assisted living facility
- History of previous serious adverse transfusion reaction
- Exclusion Criteria for Caregivers:
- Age \< 18 years
Exclusion
Key Trial Info
Start Date :
September 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2029
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT06487247
Start Date
September 10 2025
End Date
May 31 2029
Last Update
September 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02215
2
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215